Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sprout Health vs Direct Meds

Sprout Health
Graded #12

Higher grade

vs+4
Direct Meds
Graded #32

Lower grade

The verdict

Sprout Health takes it — 86/100 to 82/100.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSprout Health +5
90
85
Dose & formulationDirect Meds +6
82
88
Clinical oversightSprout Health +8
88
80
Labs & monitoringSprout Health +14
92
78
FulfillmentDirect Meds +2
78
80
Contract termsSprout Health +4
84
80
Sprout Health · left barDirect Meds · right bar

The numbers

MetricSprout HealthDirect Meds
WeighScore86/10082/100
GradeBB−
Scorecard rank#12#32
Semaglutide$149/mo$179/mo
Tirzepatide$199/mo$224/mo
CoverageNot disclosedNot publicly listed
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Sprout Health

Graded #12 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight
Direct Meds

Graded #32 · B−

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 37 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard